ARCHIVES

Advanced Ovarian Cancer Responds To Irofulven In Phase II Studies

This article is from The Cancer Letter archive.

Vol. 24 No. 10 | October 26, 2001

Download PDF Visit The Full Archive

Related Articles

NIH Says Its Probe Found Charges Of Double Payment “Basically Correct”

October 23, 1981

Studies Seek to Identify High-Risk Groups to Justify Mammography Screening at 40

May 4, 2012

COMMIT Moving Into Implementation

July 15, 1988

House Committee Begins Investigation Of NCI’s National Lung Screening Trial.

October 26, 2007

NIH, Lasker Foundation Offer Clinical Research Opportunity

December 10, 2010

Two More Treatment Programs Moved To DCT; Rauscher Ponders Fate of Cooperative Groups

April 18, 1975